New hope for teens with stubborn hives: drug trial launches
NCT ID NCT05677451
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called remibrutinib in teenagers aged 12 to 17 who have chronic spontaneous urticaria (hives that come and go for no clear reason) that isn't controlled by antihistamines. About 100 participants will receive either the drug or a placebo for 24 weeks, with an option to continue treatment for up to 3 more years. The goal is to see if the drug reduces itching and hives better than a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remibrutinib (a drug that targets inflammation to reduce hives and itching)
What this could lead to
If it works, this could provide a new treatment option for teenagers with chronic hives that don't respond to standard antihistamines.
What could go wrong
This is a Phase 3 trial, but it's still early for this age group. The drug may not work better than placebo, and side effects are possible. Long-term safety is still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Allergy Associates of Utah
COMPLETEDSandy City, Utah, 84093, United States
-
Allergy Asthma and Clinical Research
RECRUITINGOklahoma City, Oklahoma, 73120, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Allergy and Asthma Medical Group and Research Center
RECRUITINGSan Diego, California, 92123, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Allergy and Asthma Specialist P S C
RECRUITINGOwensboro, Kentucky, 42301, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Allergy and Clinical Immunology Associates
ACTIVE_NOT_RECRUITINGPittsburgh, Pennsylvania, 15241, United States
-
Endeavor Health
ACTIVE_NOT_RECRUITINGGlenview, Illinois, 60077, United States
-
Kern Research
RECRUITINGBakersfield, California, 93301, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novartis Investigative Site
RECRUITINGCABA, Buenos Aires, 1280, Argentina
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGCABA, Buenos Aires, C1414AIF, Argentina
-
Novartis Investigative Site
RECRUITINGCaba, Buenos Aires, C1425BEN, Argentina
-
Novartis Investigative Site
RECRUITINGRosario, Santa Fe Province, 2000, Argentina
-
Novartis Investigative Site
RECRUITINGRosario, Santa Fe Province, S2000JKR, Argentina
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGCABA, C1181ACH, Argentina
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSan Miguel de Tucumán, 4000, Argentina
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSantiago, Santiago Metropolitan, 8420383, Chile
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGGuangzhou, Guangdong, 510091, China
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGChengdu, Sichuan, 610041, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100050, China
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGBeijing, 100069, China
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGFrankfurt am Main, Hesse, 60590, Germany
-
Novartis Investigative Site
COMPLETEDBerlin, 13353, Germany
-
Novartis Investigative Site
WITHDRAWNMainz, 55131, Germany
-
Novartis Investigative Site
RECRUITINGMünster, 48149, Germany
-
Novartis Investigative Site
COMPLETEDTübingen, 72076, Germany
-
Novartis Investigative Site
RECRUITINGHong Kong, 999077, Hong Kong
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGHong Kong, 999077, Hong Kong
-
Novartis Investigative Site
RECRUITINGBari, BA, 70126, Italy
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGFlorence, FI, 50139, Italy
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGParma, PR, 43126, Italy
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGPavia, PV, 27100, Italy
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSiena, SI, 53100, Italy
-
Novartis Investigative Site
RECRUITINGTrieste, TS, 34137, Italy
-
Novartis Investigative Site
RECRUITINGNaples, 80138, Italy
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKitakyushu, Fukuoka, 8078556, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKamimashi-gun, Kumamoto, 861-3106, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSakai, Osaka, 5938324, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGIzumo, Shimane, 6938501, Japan
-
Novartis Investigative Site
COMPLETEDItabashi-ku, Tokyo, 1738610, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKuching, Sarawak, 93586, Malaysia
-
Novartis Investigative Site
WITHDRAWNDeventer, Overijssel, 7416 SE, Netherlands
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGUtrecht, 3584 CX, Netherlands
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGLodz, 90-436, Poland
-
Novartis Investigative Site
WITHDRAWNOlsztyn, 10-045, Poland
-
Novartis Investigative Site
WITHDRAWNWarsaw, 02-962, Poland
-
Novartis Investigative Site
WITHDRAWNSingapore, 119074, Singapore
-
Novartis Investigative Site
WITHDRAWNSingapore, 229899, Singapore
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGPretoria, Gauteng, 0181, South Africa
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGCape Town, 7925, South Africa
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGEsplugues, Barcelona, 08950, Spain
-
Novartis Investigative Site
WITHDRAWNBarcelona, 08035, Spain
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGValencia, 46014, Spain
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSongkhla, Hat Yai, 90110, Thailand
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGBangkok, 10330, Thailand
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGBangkok, 10700, Thailand
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGIstanbul, Fatih, 34093, Turkey (Türkiye)
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGAnkara, Sihhiye-Altindag, 06230, Turkey (Türkiye)
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGAdana, 01330, Turkey (Türkiye)
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGPeterborough, Cambridgeshire, PE3 9GZ, United Kingdom
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGManchester, M13 9WL, United Kingdom
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGSouthampton, SO16 6YD, United Kingdom
-
Pediatric Dermatology of Miami at the Pediatric CoE
RECRUITINGMiami, Florida, 33156, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
RFSA Dermatology
RECRUITINGSan Antonio, Texas, 78213, United States
Contact Email: •••••@•••••
Contact
-
Seattle Allergy and Asthma Rsch
WITHDRAWNSeattle, Washington, 98115, United States
-
Toledo Institute of Clinical Research
ACTIVE_NOT_RECRUITINGToledo, Ohio, 43617, United States
-
Treasure Valley Medical Research
ACTIVE_NOT_RECRUITINGBoise, Idaho, 83706, United States